Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 060626
Company: WYETH AYERST
Company: WYETH AYERST
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
OMNIPEN-N | AMPICILLIN SODIUM | EQ 125MG BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
OMNIPEN-N | AMPICILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
OMNIPEN-N | AMPICILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
OMNIPEN-N | AMPICILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
OMNIPEN-N | AMPICILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |